1.
Journal of the Korean Cancer Association
; : 512-515, 1997.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-182887
RESUMO
A 56-year-old male patient with non-Hodgkin's lymphoma achieved complete remission in July 1994 after receiving MACOP-B chemotherapy. 29 months after treatment, acute myeloid leukemia (AML, FAB subtypes M4) with trisomy 9 was developed. To our knowledge this is the first report of therapy-related AML with trisomy 9.
